Pulse Brain · Growing Health Evidence Index
Tier 2 — RCT, large cohort or strong causal designPeer-reviewed

Conjugated Linoleic Acid‐Enriched Fermented Dairy Modulates Microbiota and Metabolites to Alleviate MASLD: Insights From Multi‐Omics and Causal Mediation Analysis

Fei Mi; Yan-Jiao Wang; Jia Xiong; Yi-Yuan Ma; Hong-Mei Pan; Jianzhong Yin; Yun-Mei Chai; Yao Wang; Xin Xu; Ai-Jia Zhang; Qingwen Ma; Hui Wang; Dong-Bai Liu; Shaoxiong Wu

Food Frontiers · 2026

Read source ↗ All evidence

Summary

This 120-day randomised controlled trial in 60 MASLD patients evaluated the therapeutic potential of conjugated linoleic acid-enriched fermented dairy using multi-omics and causal inference methods. The intervention significantly reduced liver function markers and inflammatory biomarkers whilst promoting beneficial shifts in gut microbiota composition and energy metabolism pathways. Causal mediation analysis identified specific bacterial taxa and metabolites as key mediators linking dietary CLA to clinical improvements, highlighting the value of mechanistic multi-omics approaches in understanding diet–host–microbiota interactions in metabolic disease.

Regional applicability

The trial methodology and findings are potentially applicable to United Kingdom populations with MASLD, as the condition's epidemiology and underlying pathophysiology are comparable. However, the study geography is not explicitly stated in the abstract; transferability to UK clinical practice would depend on confirmation of the study location, replication in UK cohorts, and alignment with current National Health Service dietary guidance for metabolic liver disease management.

Key measures

Serum ALT, total cholesterol, creatinine, hs-CRP; gut microbiota composition (16S rRNA); serum metabolites (untargeted LC–MS); causal mediation analysis

Outcomes reported

The study measured changes in liver function markers (ALT, total cholesterol, creatinine, hs-CRP), gut microbiota composition via 16S rRNA sequencing, and serum metabolites via LC–MS metabolomics in MASLD patients after 120 days of CLA-enriched fermented dairy consumption. Causal mediation analyses identified mechanistic links between the intervention, microbiota shifts, metabolic changes, and clinical improvements.

Theme
Nutrition & health
Subject
Gut microbiome & human health
Study type
Research
Study design
RCT
Source type
Peer-reviewed study
Status
Published
System type
Dairy
DOI
10.1002/fft2.70349
Catalogue ID
NRmu8gjnhw-00t

Topic tags

Pulse AI · ask about this record

Dig deeper with Pulse AI.

Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.